Ignite Creation Date:
2025-12-25 @ 4:09 AM
Ignite Modification Date:
2025-12-26 @ 3:06 AM
Study NCT ID:
NCT00151320
Status:
COMPLETED
Last Update Posted:
2018-06-19
First Post:
2005-09-06
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Phase I/II Trial of VELCADE + CHOP-Rituximab in Untreated DLCBL or Mantle Cell NHL
Sponsor:
Weill Medical College of Cornell University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-01
Start Date Type:
ACTUAL
Primary Completion Date:
2010-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-04-24
Completion Date Type:
ACTUAL
First Submit Date:
2005-09-06
First Submit QC Date:
None
Study First Post Date:
2005-09-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-02-23
Results First Submit QC Date:
None
Results First Post Date:
2017-04-07
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-05-25
Last Update Post Date:
2018-06-19
Last Update Post Date Type:
ACTUAL